125 related articles for article (PubMed ID: 38602239)
1. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
Zhang Y; Li L; Han Q; Wen L
J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
[TBL] [Abstract][Full Text] [Related]
2. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
3. Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.
Zeng L; Sun X
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984496
[No Abstract] [Full Text] [Related]
4. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
5. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY
Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of HS6ST2 Inhibits Cervical Cancer Cell Migration and Invasion
Li S; Shen H; Wan Q; Chen P; Shu C; Wang H; Zhu W
Discov Med; 2023 Dec; 35(179):1147-1159. PubMed ID: 38058080
[TBL] [Abstract][Full Text] [Related]
7. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
10. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
11. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
13. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study of pelvic and para-aortic lymph nodes positivity in stage 1A to 2A cervical cancer patients.
John Lim BB; Yong CM
Med J Malaysia; 2021 Jul; 76(4):534-540. PubMed ID: 34305115
[TBL] [Abstract][Full Text] [Related]
15. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
Qin R; Cao L; Wang J; Liu J
Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
[TBL] [Abstract][Full Text] [Related]
16. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Lymph Node Metastasis and Risk Factors in 975 Patients with FIGO 2009 Stage IA-IIA Cervical Cancer.
Cao L; Kong W; Li J; Song D; Jin B; Liu T; Han C
Gynecol Obstet Invest; 2023; 88(1):30-36. PubMed ID: 36450266
[TBL] [Abstract][Full Text] [Related]
18. Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery.
Fan X; Wang Y; Yang N; Zhu P
World J Surg Oncol; 2023 Jun; 21(1):186. PubMed ID: 37344912
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
Cao W; Peng T; Zhou Y
J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
[TBL] [Abstract][Full Text] [Related]
20. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]